35 results
PRER14A
BXRX
Baudax Bio, Inc.
25 Aug 23
Preliminary revised proxy
4:01pm
, in the European Union, we may submit applications for marketing authorizations either under a centralized, decentralized, or mutual recognition marketing … Commission on the basis of a positive opinion by the European Medicines Agency. A centralized marketing authorization is valid for all European Union
DEFA14A
EX-99.1
BXRX
Baudax Bio, Inc.
9 Aug 23
Additional proxy soliciting materials
5:28pm
apply to any product that is approved outside the United States.
For example, in the European Union, we may submit applications for marketing … Medicines Agency. A centralized marketing authorization is valid for all European Union member states and three of the four European Free Trade Association
8-K/A
EX-99.1
BXRX
Baudax Bio, Inc.
9 Aug 23
Other Events
5:27pm
apply to any product that is approved outside the United States.
For example, in the European Union, we may submit applications for marketing … Medicines Agency. A centralized marketing authorization is valid for all European Union member states and three of the four European Free Trade Association
DEFA14A
3nolou txtnqeu9
5 Jul 23
Additional proxy soliciting materials
5:28pm
8-K
EX-2.1
omq1k
5 Jul 23
Entry into a Material Definitive Agreement
5:26pm
8-K
EX-1.1
snew4m
1 Mar 22
Entry into a Material Definitive Agreement
7:01am
8-K
EX-10.1
n4oew kvtng0m0
2 Jun 20
Entry into a Material Definitive Agreement
7:45am
424B5
upsfv4qjpqwvci2ep
24 Mar 20
Prospectus supplement for primary offering
5:04pm
8-K
EX-1.1
eedqk1s2u4i9
24 Mar 20
Baudax Bio Announces Pricing of Public Offering of Common Stock and Warrants
9:33am
424B5
pg0 eadp7h
23 Mar 20
Prospectus supplement for primary offering
5:27pm
10-K
4iucv
13 Feb 20
Annual report
5:05pm
S-3
EX-4.3
qney09clbp
6 Dec 19
Shelf registration
5:26pm
8-K
EX-99.1
czwfuedt
26 Nov 19
Entry into a Material Definitive Agreement
4:53pm